Clinical Trials Browser

Approved for marketing × Fluorouracil × Clear all

NCT02436044 2019-08-20

HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC

Approved for marketing

Gastrointestinal

Carcinoma, Hepatocellular, Wounds and Injuries

NCT00786058 2009-06-15

A Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003

Approved for marketing

Gastrointestinal

Pancreatic Neoplasms